THE PROGNOSTIC ROLE OF THE ELF TEST, COMPARED TO LIVER BIOPSY, IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)

被引:0
|
作者
Liguori, A. [1 ]
D'Ambrosio, F. [2 ]
Nicholas, V. [1 ]
Termite, F. [1 ]
Petrucci, L. [1 ]
Beschi, R. [1 ]
Orienti, M. [2 ]
Galletti, S. [2 ]
Cardinali, S. [2 ]
Riccardi, L. [1 ]
Pizzolante, F. [1 ]
De, Matthaeis N. [1 ]
Zocco, M. A. [1 ]
Giustiniani, M. C. [3 ]
Marrone, G. [1 ]
Biolato, M. [1 ]
Cefalo, C. [1 ]
Vecchio, F. M. [3 ]
Pompili, M. [1 ]
Rapaccini, G. L. [1 ]
Grieco, A. [1 ]
Urbani, A. [2 ]
Sanguinetti, M. [2 ]
Gasbarrini, A. [1 ]
Miele, L. [1 ]
机构
[1] Fdn Policlin Univ Agostino Gemelli IRCCS, Dept Traslat Med & Surg, Rome, Italy
[2] Fdn Policlin Univ A Gemelli IRCCS, Dept Lab & Infect Sci, Rome, Italy
[3] Fdn Policlin Univ A Gemelli IRCCS, Dept Women Children & Publ Hlth Sci, Rome, Italy
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
T.07.5
引用
收藏
页码:S257 / S257
页数:1
相关论文
共 50 条
  • [41] Metabolic dysfunction-associated steatotic liver disease in children
    Goyal, Nidhi P.
    Xanthakos, Stavra
    Schwimmer, Jeffrey B.
    GUT, 2025,
  • [42] Menopause and metabolic dysfunction-associated steatotic liver disease
    Polyzos, Stergios A.
    Goulis, Dimitrios G.
    MATURITAS, 2024, 186
  • [43] Genome-wide Association Study on Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
    Darlay, Rebecca
    Zatorska, Michalina
    Worthington, Sarah
    Anstee, Quentin M.
    Daly, Ann K.
    Cordell, Heather J.
    GENETIC EPIDEMIOLOGY, 2024, 48 (07) : 352 - 352
  • [44] Cutting edge: ferroptosis in metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis and therapy
    El-Sehrawy, Amr Ali Mohamed Abdelgawwad
    Rashid, Teeba Ammar
    Ullah, Muhammad Ikram
    Uthirapathy, Subasini
    Ganesan, Subbulakshmi
    Singh, Abhayveer
    Devi, Anita
    Joshi, Kamal Kant
    Jasim, Ahmed Salman
    Kadhim, Abed J.
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2025, 25 (01)
  • [45] THE ROLE OF REVISIONAL ENDOSCOPIC SLEEVE GASTROPLASTY (RESG) TO TREAT METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Hedjoudje, Abdellah
    Hoff, Anna C.
    Nunes, Gabriel C.
    Barrichello, Sergio
    Huang, Yuting
    Patel, Tushar
    Kumbhari, Vivek
    Badurdeen, Dilhana S.
    GASTROENTEROLOGY, 2024, 166 (05) : S1638 - S1639
  • [46] Novel insights of phenylalanine in Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) and cardiovascular complications
    Liu, J.
    Chen, Y.
    Qian, J.
    Cui, R.
    Demirkan, A.
    Zheng, Y.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [47] METALD, THE NEW CATEGORY OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) - HOW COMMON IS IT?
    Scheetz, Kate
    Kalagara, Sanah
    Vilar-Gomez, Eduardo
    Chalasani, Naga P.
    Vuppalanchi, Raj
    GASTROENTEROLOGY, 2024, 166 (05) : S477 - S478
  • [48] Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance
    Hutchison, Alan L.
    Tavaglione, Federica
    Romeo, Stefano
    Charlton, Michael
    JOURNAL OF HEPATOLOGY, 2023, 79 (06) : 1524 - 1541
  • [49] USEFULNESS OF SERUM MICRORNAS AS BIOMARKERS FOR PEDIATRIC METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Blakley, Caroline
    Nelson, Benjamin
    Qarooni, Shatha
    Lee, Wai Han
    Tryggestad, Jeanie
    Short, Kevin
    Palle, Sirish Kumar
    HEPATOLOGY, 2024, 80 : S626 - S626
  • [50] HEALTHCARE PROVIDERS' PERSPECTIVES ON NEW METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) NOMENCLATURE
    Albhaisi, Somaya
    Albhaisi, Omar
    HEPATOLOGY, 2024, 80 : S890 - S891